HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert® HPV assay

Journal of Clinical Virology

Volumn 87, Issue , 2017, Pages 1-4

  Cubie, Heather A ^a   Morton, David ^b   Kawonga, Edson ^c   Mautanga, Mike ^c   Mwenitete, Ipyana ^c   Teakle, Ngari ^c   Ngwira, Bagrey ^d   Walker, Hilary ^e   Walker, Graeme ^e   Kafwafwa, Savel ^b   Kabota, Beatrice ^b   Ter Haar, Reynier ^b   Campbell, Christine ^f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Social Dimensions of Health Institute   (Malawi)

^c Nkhoma Hospital Laboratory   (Malawi)

^d UNIVERSITY OF MALAWI   (Malawi)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

HPV prevalence; Low and middle income countries (LMICs); Xpert HPV

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; IMMUNOASSAY; MALAWI; NORMAL HUMAN; POLYMERASE CHAIN REACTION SYSTEM; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; RURAL HEALTH CARE; SPECIMEN HANDLING; TURNAROUND TIME; UTERINE CERVIX CYTOLOGY; WART VIRUS; ADOLESCENT; CLASSIFICATION; EARLY CANCER DIAGNOSIS; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR DIAGNOSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PROCEDURES; RURAL POPULATION; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MALAWI; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RURAL POPULATION; TIME FACTORS; YOUNG ADULT;

EID: 85004097296     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2016.11.014     Document Type: Article

References (20)

1. [1] Bouvard, V., Baan, R., Straif, K., WHO International Agency for research on cancer Monograph working Group, A review of human carcinogens—part B: biological agents. Lancet Oncol. 10 (2009), 321–322.
2. [2] Denny, L.A., Franceschi, S., de Sanjose, S., Heard, I., Moscicki, A.B., Palefsky, J., Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 30:Suppl. 5 (2012), F168–F174.
3. [3] Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. 2014, International Agency for Research on Cancer, Lyon, France Available from: http://globocan.iarc.fr, Accessed on 16 January 2016.
4. [4] Maseko, F.C., Chirwa, M.L., Muula, A.S., Health systems challenges in cervical cancer prevention program in Malawi. Global Health Action, 8, 2015, 26282, 10.3402/gha.v8.26282.
5. [5] Sankaranarayanan, R., Screening for cancer in low- and middle-income countries. Ann. Global Health 80:September-October (5) (2014), 412–417, 10.1016/j.aogh.2014.09.014.
6. [6] Joshi, S., Sankaranarayanan, R., Muwonge, R., Kulkarnic, V., Somanathand, T., Divatea, U., Screening of cervical neoplasia in HIV-infected women in India. AIDS 27 (2013), 607–615.
7. [7] Qiao, Y.L., Sellors, J.W., Eder, P.S., Bao, Y.P., Lim, J.M., Zhao, F.H., A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 9 (2008), 929–936.
8. [8] Jeronimo, J., Bansil, P., Lim, J., Peck, R., Paul, P., Amador, J.J., START-UP Study Group, et al. A multi-country evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int. J. Gynecol. Cancer 24:3 (2014), 576–585 PMID: 24557438.
9. [9] Zhao, F.-H., Jeronimo, J., Qiao, Y.-L., Schweizer, J., Chen, W., Valdez, M., An evaluation of novel, lower cost molecular screening tests for human papillomavirus in rural China. Cancer Prev. Res. 6 (2013), 938–948.
10. [10] Castle, P.E., Smith, K.M., Davis, T.E., Reliability of the Xpert HPV assay to detect high-risk Human Papilloma virus DNA in a colposcopy referral population. Am. J. Clin. Pathol. 143:1 (2015), 126–133.
11. [11] Einstein, M.H., Smith, K.M., Davis, T.E., Clinical evaluation of the cartridge-based GeneXpert Human Papilloma virus assay in women referred for colposcopy. J. Clin. Microbiol. 52:6 (2014), 2089–2095.
12. [12] Cuzick, J., Cuschieri, K., Denton, K., Hopkins, M., Thorat, M.A., Wright, C., Cubie, H., Moore, C., Kleeman, M., Austin, J., Ashdown-Barr, L., Hunt, K., Cadman, L., Performance of the Xpert HPV assay in women attending for cervical screening. Papillomavirus Res., 2015, 10.1016/j.pvr.2015.05.002 online June 16. ISSN 2405-8521.
13. [13] Campbell, C., Kafwafwa, S., Brown, H., Walker, G., Madetsa, B., Deeny, M., Kabota, B., Morton, D., Ter Haar, R., Grant, L., Cubie, H.A., Use of thermo-coagulation as an alternative treatment modality in a ‘screen and treat’ programme of cervical screening in rural Malawi. Int. J. Cancer(May (4)), 2016, 10.1002/ijc.30101.
14. [14] Luchters, S.M.F., Vanden Broeck, D., Cherisch, M.F., Nel, A., Delva, W., Mandaliya, K., Depuydt, C.E., Claeys, P., Bogers, J.P., Temmerman, M., Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect. Dis. 10 (2010), 18–28, 10.1186/1471-2334-10-PMID:20102630.
15. [15] Tenthani, L., Haas, A.D., Egger, M., Van Oosterhout, J.J.V., Jahn, A., Chimbwandira, F., Tal, K., Myer, L., Estill, J., Keiser, O., HIV testing among pregnant women who attend antenatal care in Malawi. J. Acquir. Immune Defic. Syndr. 69 (2015), 610–614.
16. [16] L. Bruni, L. Barrionuevo-Rosas, G. Albero, M. Aldea, B. Serrano, S. Valencia, et al., X. ICO Information Centre on HPV and Cancer (HPV Information Centre), Human Papillomavirus and Related Diseases in the World, Summary Report 2014-12-18.
17. [17] Arbyn, M., Depuydt, C., Benoy, I., Bogers, J., Cuschieri, K., Schmitt, M., et al. VALGENT: a protocol for clinical validation of human papillomavirus assays. J. Clin. Virol. 76 (2016), S14–S21.
18. [18] Guan, P., Howell-Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., Clifford, G.M., Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int. J. Cancer 131:10 (2012), 2349–2359, 10.1002/ijc.27485 PMID:22323075.
19. [19] Clifford, G., Franceschi, S., Diaz, M., Munoz, N., Villa, L.L., HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24:Suppl. 3 (2006), 26–34 PMID:16950015.
20. [20] McKenzie, N., Kobetz, E.N., Hnatyssyn, J., Twiggs, L.B., Lucci, J.A., Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol. Oncol. 116 (2010), 572–577.